PTK7 helps detect T lymphoblastic leukemia/lymphoma by flow cytometry
Cytometry Part B: Clinical Cytometry · 2025
DOI: 10.1002/cyto.b.22228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytometry Part B: Clinical Cytometry, 2025. Verfasst von Jonah Maggard und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Florida College of Medicine, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Flow Cytometry, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Receptor Protein-Tyrosine Kinases, Cell Adhesion Molecules. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
T lymphoblastic leukemia/lymphoma (T‐ALL) is a malignancy composed of proliferating T lymphoblasts. T lymphoblasts can be identified by flow cytometric analysis through the detection of aberrant antigen expression and/or immaturity marker expression. An ideal marker would be expressed brightly on T lymphoblasts but absent in mature T lymphocytes. One such marker is protein tyrosine kinase‐7 (PTK7). However, PTK7 has not been widely adopted in clinical flow cytometry labs or incorporated into any T‐ALL flow cytometry best practice recommendations. To this end, we demonstrate the utility of PTK7 in flow cytometry panels for T‐ALL diagnosis, minimal/measurable residual disease (MRD) detection, and relapse. We retrospectively evaluated flow cytometry data on 175 patients. PTK7 was classified as positive, showing a near two‐fold difference in brightness versus background mature T cells, in 87.76% of T‐ALL cases at initial diagnosis, 75% of T‐ALL at MRD, and 100% of T‐ALL at relapse. PTK7 expression remained intact in cases of CD34 and/or TdT negative T‐ALL ( p = 0.992) and while expression was dimmer at MRD (72% decrease, p = 0.0313), PTK7 remained intact at relapse (33% increase, p = 0.8125). PTK7 should be included in flow cytometry panels when evaluating for T‐ALL, both at initial diagnosis, relapse, and for the presence of MRD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Florida College of Medicine, Gainesville, Florida, USA.
- Department of Pathology, Immunology and Laboratory Medicine, Gainesville, Florida, USA.
ORCID-Profile: Robert Seifert
Zitieren
APA
Maggard, J., Yang, Y., Chaffin, J., Gars, E., Yang, L., & Seifert, R. (2025). PTK7 helps detect T lymphoblastic leukemia/lymphoma by flow cytometry. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.22228
Vancouver
Maggard J, Yang Y, Chaffin J, Gars E, Yang L, Seifert R. PTK7 helps detect T lymphoblastic leukemia/lymphoma by flow cytometry. Cytometry Part B: Clinical Cytometry. 2025. doi:10.1002/cyto.b.22228
BibTeX
@article{Maggard2025,
author = {Maggard, Jonah and Yang, Yu and Chaffin, Joanna and Gars, Eric and Yang, Lijun and Seifert, Robert},
title = {PTK7 helps detect T lymphoblastic leukemia/lymphoma by flow cytometry},
journal = {Cytometry Part B: Clinical Cytometry},
year = {2025},
doi = {10.1002/cyto.b.22228}
}
EUVIMED